Open AccessP1007: PHASE 2, OPEN‐LABEL, MULTICENTER, SINGLE‐ARM STUDY INVESTIGATING THE EFFICACY AND SAFETY OF ROPEGINTERFERON ALFA‐2B IN JAPANESE PATIENTS WITH POLYCYTHEMIA VERA
Author(s) -
Kirito K.,
Edahiro Y.,
Ohishi K.,
Gotoh A.,
Takenaka K.,
Shibayama H.,
Shimizu T.,
Usuki K.,
Shimoda K.,
Ito M.,
VanWart S. A.,
Zagrijtschuk O.,
Qin A.,
Kawase H.,
Miyachi N.,
Sato T.,
Komatsu N.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000846896.29524.36
Subject(s) - medicine , polycythemia vera , phlebotomy , tolerability , interferon alfa , gastroenterology , clinical endpoint , phases of clinical research , surgery , clinical trial , adverse effect , cancer , immunotherapy